[MOL] About Herceptin Findings [01889] Medicine On Line


[Date Prev][Date Next][Thread Prev][Thread Next][Date Index][Thread Index]

[MOL] About Herceptin Findings





Herceptin Improves Survival In Metastatic Breast Cancer Patients
With HER-2/neu Gene Mutation

PHILADELPHIA, Apr 14 (Reuters Health) - In a presentation at the
90th annual meeting of the American Association for Cancer
Research, Dr.  Dennis Slamon presented data showing a survival
benefit linked to trastuzumab (Herceptin) treatment of a subset
of metastatic breast cancer patients.  Dr.  Slamon, director of
the Revlon/UCLA Women's Cancer Research Program, UCLA School of
Medicine, presented the 2-year data in a plenary presentation on
Tuesday.  Last fall, based on 1-year results from a phase III
trial, the Food and Drug Administration approved Herceptin for
treatment of metastatic breast cancer.

I am hoping that Herceptin will be utilized in Ovarian cancer as well
and will have similar successes.

God Bless YOu All
marty auslander
------------------------------------------------------------------------
This is an automatically-generated notice.  If you'd like to be removed
from the mailing list, please visit the Medicine-On-Line Discussion Forum
at <http://www.meds.com/con_faq.html>, or send an email message to:
majordomo@lists.meds.com
with the subject line blank and the body of the message containing the line:
unsubscribe mol-cancer your-email-address
where the phrase your-email-address is replaced with your actual email
address.
------------------------------------------------------------------------